Prosecution Insights
Last updated: October 25, 2026
Application No. 17/758,306

Method of Mass Analysis - Controlling Viscosity of Solvent for OPP Operation

Final Rejection §103
Filed
Jul 01, 2022
Priority
Jan 14, 2020 — provisional 62/960,735 +1 more
Examiner
GZYBOWSKI, MICHAEL STANLEY
Art Unit
1798
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Dh Technologies Development Pte. Ltd.
OA Round
4 (Final)
68%
Grant Probability
Favorable
5-6
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
115 granted / 170 resolved
+2.6% vs TC avg
Strong +52% interview lift
Without
With
+52.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
59 currently pending
Career history
263
Total Applications
across all art units

Statute-Specific Performance

§101
3.1%
-36.9% vs TC avg
§103
53.4%
+13.4% vs TC avg
§102
15.3%
-24.7% vs TC avg
§112
25.7%
-14.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 170 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Remarks This Office Action fully acknowledges Applicant’s remarks filed on 06/24/2026 Claims 1-11 and 14-17 are pending. Claim 15 is withdrawn. Claims 1-11 and 14 have been amended. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. 1. Claims 1-11, 16 and 17 are rejected under 35 U.S.C. 103 as being unpatentable over U.S. Patent Application Publication No. 2019/0157061 to Datwani et al. in view of U.S. Patent Application Publication No. 2017/0315032 to Basiji et al. Regarding applicant’s claim 1, Datwani et al. teaches a system for transporting analytes to an analytical instrument (mass analyzer 170) that, as shown in Figs. 1A and 1B includes a reservoir (13) housing a fluid sample containing an analyte; an ejector (33) that ejects a droplet of the fluid sample from the fluid surface; and a continuous flow open port probe (51) spaced apart from the fluid surface that includes (i) a sampling tip (53) for receiving the ejected droplet of the fluid sample, (ii) a solvent inlet (57) for receiving a solvent from a solvent source, (iii) a solvent transport capillary (59) for transporting the solvent from the solvent inlet to the sampling tip, where the ejected droplet combines with the solvent to form an analyte-solvent dilution, (iv) a sample outlet (63) through which the analyte-solvent dilution is directed away from the OPP to an analytical instrument and (v) a sample transport capillary (73) for transporting the analyte-solvent dilution from the sampling tip to the sample outlet, wherein the sample transport capillary and the solvent transport capillary are in fluid communication at the sampling tip. [0101], [0109]-[0111] Datwani et al. teaches a gas inlet 67 through which a nebulizing gas is configured to flow from a gas source to the sample outlet. Datwani et al. teaches that “The analyte-solvent dilution flow is then drawn upward through the sample transport capillary 61 by the pressure drop generated as the nebulizing gas passes over the sample outlet 63 and combines with the fluid exiting the sample transport capillary 61. A gas pressure regulator is used to control the rate of gas flow into the system via gas inlet 67.” [0110] Datwani et al. teaches that “the flow rate of liquid within the sampling probe 51 can be adjusted based, for example, on suction/aspiration force generated by the interaction of the nebulizer gas and the analyte-solvent dilution as it is being discharged from the electrospray electrode 164 (e.g., due to the Venturi effect).” [0115]. Note applicant’s claiming that gas inlet through which a nebulizing gas “is configured” to flow from a gas source to the sample outlet so that the analyte-solvent dilution is drawn out of the sample outlet by the Venturi effect…and that the gas pressure regulator “is configured” to reduce the nebulizing gas flow as the solvent is heated by the heating element in order to maintain a constant flow of the analyte-solvent dilution through the sample transport capillary, are directed to how the elements of the system are used and do not limit the structural elements claimed. The corresponding gas inlet, nebulizing gas and pressure regulated taught by Datwani et al. are capable of operating in the same manner as applicant’s claimed gas inlet, nebulizing has and pressure regulator. Therefore, Datwani et al. teaches applicant’s claimed gas inlet through which a nebulizing gas is configured to flow and gas pressure regulator operably connected to the gas inlet to control the nebulizing gas flow, wherein the gas pressure regulator is configured to reduce the nebulizing gas flow. Datwani et al. does not teach a heating element that heats the solvent to a temperature above a threshold temperature in order to reduce a viscosity of the solvent below a threshold viscosity and maintain the viscosity of the solvent below the threshold viscosity as the analyte-solvent dilution is transported from the sampling tip to the sample outlet. However, at [0086] Datwani et al. teaches that the volume of a homogeneous fluid passing per unit time through a capillary tube is directly proportional to the pressure difference between its ends and to the fourth power of its internal radius and is inversely proportional to its length and to the viscosity of the fluid. Accordingly, decreasing the viscosity of the solvent in Datwani et al. that passes through the solvent inlet 57 and solvent capillary 59 and inner capillary tube 73 would increase the flow of solvent thought the solvent capillary 59 and inner capillary tube 73 Basiji et al. teaches biological sample processing systems and methods in which liquid reagents are used. In paragraph [0064] Basiji et al. teaches that liquid reagents are heated to reduce viscosity and improve flow and that the reagents may be heated by heater 120. It would have been obvious to one of ordinary skill in the art before applicant’s effective filing date to modify Datwani et al. to include a heating element to heat the solvent and reduce the viscosity of the solvent as taught by Basiji et al. for purposes of controlling and improving the flow rate of the solvent. I.) Regarding applicant’s claim 1, as noted above Datwani et al. in view of Basiji et al. renders all the limitations of claim 1 obvious. Therefore, Datwani et al. in view of Basiji et ai. renders claim 1 obvious. II.) Regarding applicant’s claim 2, as noted above Datwani et al. in view of Basiji et ai. renders claim 1 obvious from which claim 2 depends. Claim 2 recites that the heating element is located before, surrounding, or in line with the solvent inlet. Datwani et al. in view of Basiji et ai. does not teach that the heating element is located before, surrounding, or in line with the solvent inlet. In Datwani et al. in view of Basiji et ai. it would have been obvious to one of ordinary skill in the art before applicant’s effective filing date to provide a heating element (in view of Basiji et al. teaching a heater) at any location at which the solvent can be heated, including before, surrounding or in line with the solvent inlet. Therefore, Datwani et al. in view of Basiji et ai. renders claim 2 obvious. III.) Regarding applicant’s claim 3, as noted above Datwani et al. in view of Basiji et ai. renders claim 1 obvious from which claim 3 depends. Claim 3 recites that the heating element is located before, surrounding, or in line with the solvent transport capillary. Datwani et al. in view of Basiji et ai. does not teach that the heating element is located before, surrounding, or in line with the solvent transport capillary. In Datwani et al. in view of Basiji et ai. it would have been obvious to one of ordinary skill in the art before applicant’s effective filing date to provide a heating element (in view of Basiji et al. teaching a heater) at any location at which the solvent can be heated, including before, surrounding or in line with the solvent transport capillary. Therefore, Datwani et al. in view of Basiji et ai. renders claim 3 obvious. IV.) Regarding applicant’s claim 4, as noted above Datwani et al. in view of Basiji et ai. renders claim 1 obvious from which claim 4 depends. Claim 4 recites a second heating element is located surrounding the sample transport capillary to maintain the viscosity of the solvent below the threshold viscosity as the analyte-solvent dilution is transported from the sampling tip to the sample outlet. Datwani et al. in view of Basiji et ai. does not teach a second heating element is located surrounding the sample transport capillary to maintain the viscosity of the solvent below the threshold viscosity as the analyte-solvent dilution is transported from the sampling tip to the sample outlet. In Datwani et al. in view of Basiji et ai. it would have been obvious to one of ordinary skill in the art before applicant’s effective filing date to include a second heating element located at any location at which the solvent can be heated, including surrounding the sample transport capillary to maintain the viscosity of the solvent below the threshold viscosity as the analyte-solvent dilution is transported from the sampling tip to the sample outlet. Note, it has held that mere duplication of parts has no patentable significance unless a new and unexpected result is produced. (MPEP 2144.04(VI)(B)) Therefore, Datwani et al. in view of Basiji et ai. renders claim 4 obvious. V.) Regarding applicant’s claim 5, as noted above Datwani et al. in view of Basiji et ai. renders claim 1 obvious from which claim 5 depends. Claim 5 recites a solvent pump operably connected to and in fluid communication with the solvent inlet for controlling solvent flow rate within the solvent transport capillary. Datwani et al. teaches a pump connected to and in fluid communication with the solvent inlet. [0021] Therefore, Datwani et al. in view of Basiji et ai. renders claim 5 obvious. VI.) Regarding applicant’s claim 6, as noted above Datwani et al. in view of Basiji et ai. renders claim 1 obvious from which claim 6 depends. Claim 6 recites that the heating element is located in or surrounding the solvent pump. Datwani et al. in view of Basiji et ai. does not teach a heating element is located in or surrounding the solvent pump. In Datwani et al. in view of Basiji et ai. it would have been obvious to one of ordinary skill in the art before applicant’s effective filing date to provide a heating element (in view of Basiji et al. teaching a heater) at any location at which the solvent can be heated, including in or surrounding the solvent pump. Therefore, Datwani et al. in view of Basiji et ai. renders claim 6 obvious. VII.) Regarding applicant’s claim 7, as noted above Datwani et al. in view of Basiji et ai. renders claim 1 obvious from which claim 7 depends. Claim 7 recites that the solvent comprises water (H20). The solvent recited in claim 7 does not further limit the structure of system of claim 1 and therefore is not afforded patentable weight. Therefore, claim 7 is obvious over Datwani et al. in view of Basiji et ai. as applied to claim 1. VIII.) Regarding applicant’s claim 8, as noted above Datwani et al. in view of Basiji et ai. renders claim 1 obvious from which claim 8 depends. Claim 8 recites that the solvent comprises at least 50 percent water (H20). The solvent recited in claim 8 does not further limit the structure of system of claim 1 and therefore is not afforded patentable weight. Therefore, claim 8 is obvious over Datwani et al. in view of Basiji et ai. as applied to claim 1. IX.) Regarding applicant’s claim 9, as noted above Datwani et al. in view of Basiji et ai. renders claim 1 obvious from which claim 9 depends. Claim 9 recites that the solvent comprises isopropyl alcohol (IPA). The solvent recited in claim 9 does not further limit the structure of system of claim 1 and therefore is not afforded patentable weight. Therefore, claim 9 is obvious over Datwani et al. in view of Basiji et ai. as applied to claim 1. X.) Regarding applicant’s claim 10, as noted above Datwani et al. in view of Basiji et ai. renders claim 1 obvious from which claim 10 depends. Claim 10 recites that the solvent comprises methanol (MeOH). The solvent recited in claim 10 does not further limit the structure of system of claim 1 and therefore is not afforded patentable weight. Therefore, claim 10 is obvious over Datwani et al. in view of Basiji et ai. as applied to claim 1. XI.) Regarding applicant’s claim 11, as noted above Datwani et al. in view of Basiji et ai. renders claim 1 obvious from which claim 11 depends. Claim 11 recites that the solvent comprises acetonitrile (ACN). The solvent recited in claim 11 does not further limit the structure of system of claim 1 and therefore is not afforded patentable weight. Therefore, claim 11 is obvious over Datwani et al. in view of Basiji et ai. as applied to claim 1. XII.) Regarding applicant’s claim 16, as noted above Datwani et al. in view of Basiji et ai. renders claim 1 obvious from which claim 16 depends. Claim 16 recites that the threshold temperature is in the range of 50-60°C. Claim 16 is directed to a manner of using the system of claim 1 and does not incorporate any additional structural elements that limit claim 1. Therefore, Datwani et al. in view of Basiji et ai. renders claim 16 obvious via rendering claim 1 obvious. XIII.) Regarding applicant’s claim 17, as noted above Datwani et al. in view of Basiji et ai. renders claim 1 obvious from which claim 17 depends. Claim 17 recites that the threshold viscosity is 0.7mPa·s or less. Claim 17 is directed to a manner of using the system of claim 1 and does not incorporate any additional structural elements that limit claim 1. Therefore, Datwani et al. in view of Basiji et ai. renders claim 17 obvious via rendering claim 1 obvious. 2. Claim 14 is rejected under 35 U.S.C. 103 as being unpatentable over Datwani et al. in view of Basiji et ai. I.) Regarding applicant’s claim 14, claim 14 recites a method for transporting an analyte in a fluid sample to an analytical instrument and controlling the viscosity of the fluid sample, comprising: ejecting a droplet from a fluid surface of a fluid sample containing an analyte that is housed in a reservoir using an ejector; pumping a solvent from a solvent source into a solvent inlet of a continuous flow open port probe (OPP) spaced apart from the fluid surface using a solvent pump in order to transport the solvent from the solvent inlet to a sampling tip of the OPP through a solvent transport capillary of the OPP, receive the ejected droplet at the sampling tip where the ejected droplet is combined with the solvent to form an analyte-solvent dilution, and transport the analyte- solvent dilution from the sampling tip to a sample output of the OPP through a sample transport capillary of the OPP; and heating the solvent to a temperature above a threshold temperature using a heating element in order to reduce a viscosity of the solvent below a threshold viscosity and maintain the viscosity of the solvent below the threshold viscosity as the analyte-solvent dilution is transported from the sampling tip to the sample outlet. Datwani et al. teaches a system for transporting analytes to an analytical instrument (mass analyzer 170) that, as shown in Figs. 1A and 1B includes a reservoir (13) housing a fluid sample containing an analyte; an ejector (33) that ejects a droplet of the fluid sample from the fluid surface; and a continuous flow open port probe (51) spaced apart from the fluid surface that includes (i) a sampling tip (53) for receiving the ejected droplet of the fluid sample, (ii) a solvent inlet (57) for receiving a solvent from a solvent source, (iii) a solvent transport capillary (59) for transporting the solvent from the solvent inlet to the sampling tip, where the ejected droplet combines with the solvent to form an analyte-solvent dilution, (iv) a sample outlet (63) through which the analyte-solvent dilution is directed away from the OPP to an analytical instrument and (v) a sample transport capillary (73) for transporting the analyte-solvent dilution from the sampling tip to the sample outlet, wherein the sample transport capillary and the solvent transport capillary are in fluid communication at the sampling tip. [0101], [0109]-[0111] Datwani et al. teaches a gas inlet 67 through which a nebulizing gas is configured to flow from a gas source to the sample outlet. Datwani et al. teaches that “The analyte-solvent dilution flow is then drawn upward through the sample transport capillary 61 by the pressure drop generated as the nebulizing gas passes over the sample outlet 63 and combines with the fluid exiting the sample transport capillary 61. A gas pressure regulator is used to control the rate of gas flow into the system via gas inlet 67.” [0110] Datwani et al. teaches that “the flow rate of liquid within the sampling probe 51 can be adjusted based, for example, on suction/aspiration force generated by the interaction of the nebulizer gas and the analyte-solvent dilution as it is being discharged from the electrospray electrode 164 (e.g., due to the Venturi effect).” [0115]. Note applicant’s claiming that gas inlet through which a nebulizing gas “is configured” to flow from a gas source to the sample outlet so that the analyte-solvent dilution is drawn out of the sample outlet by the Venturi effect…and that the gas pressure regulator “is configured” to reduce the nebulizing gas flow as the solvent is heated by the heating element in order to maintain a constant flow of the analyte-solvent dilution through the sample transport capillary, are directed to how the elements of the system are used and do not limit the structural elements claimed. The corresponding gas inlet, nebulizing gas and pressure regulated taught by Datwani et al. are capable of operating in the same manner as applicant’s claimed gas inlet, nebulizing has and pressure regulator. Therefore, Datwani et al. teaches applicant’s claimed gas inlet through which a nebulizing gas is configured to flow and gas pressure regulator operably connected to the gas inlet to control the nebulizing gas flow, wherein the gas pressure regulator is configured to reduce the nebulizing gas flow. Datwani et al. does not teach a heating element that heats the solvent to a temperature above a threshold temperature in order to reduce a viscosity of the solvent below a threshold viscosity and maintain the viscosity of the solvent below the threshold viscosity as the analyte-solvent dilution is transported from the sampling tip to the sample outlet. However, at [0086] Datwani et al. teaches that the volume of a homogeneous fluid passing per unit time through a capillary tube is directly proportional to the pressure difference between its ends and to the fourth power of its internal radius and is inversely proportional to its length and to the viscosity of the fluid. Accordingly, decreasing the viscosity of the solvent in Datwani et al. that passes through the solvent inlet 57 and solvent capillary 59 and inner capillary tube 73 would increase the flow of solvent thought the solvent capillary 59 and inner capillary tube 73 Basiji et al. teaches biological sample processing systems and methods in which liquid reagents are used. In paragraph [0064] Basiji et al. teaches that liquid reagents are heated reduce viscosity and improve flow and that the reagents may be heated by heater 120. It would have been obvious to one of ordinary skill in the art before applicant’s effective filing date to modify Datwani et al. to include a heating element to heat the solvent and reduce the viscosity of the solvent as taught by Basiji et al. for purposes of controlling and improving the flow rate of the solvent. Adjusting the using the gas regulator in Datwani et al. in view of Basiji et al. to reduce the nebulizing gas flow as the solvent is heated by the heating element in order to maintain a constant flow of the analyte-solvent dilution through the sample transport capillary as the solvent is heated by the heating element would have been obvious for purposes of compensating for viscosity changes of the solvent. As noted Datwani et al. in view of Basiji et ai. renders all the limitations of claim 14 obvious. Therefore, Datwani et al. in view of Basiji et al. renders claim 14 obvious. Response to Arguments Applicant’s arguments with respect to claims 1-11, 14, 16 and 17 have been considered but are moot because the new ground of rejection that relies upon Basiji et al. as teaching heating liquid reagents using a heater reduce viscosity and improve flow. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL S. GZYBOWSKI whose telephone number is (571)270-3487. The examiner can normally be reached M-F 8:30-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Charles Capozzi can be reached at 571-270-3638. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /M.S.G./Examiner, Art Unit 1798 /CHARLES CAPOZZI/Supervisory Patent Examiner, Art Unit 1798
Read full office action

Prosecution Timeline

Show 6 earlier events
Mar 16, 2026
Applicant Interview (Telephonic)
Apr 23, 2026
Request for Continued Examination
Apr 24, 2026
Response after Non-Final Action
May 12, 2026
Non-Final Rejection mailed — §103
Jun 24, 2026
Response Filed
Jun 24, 2026
Examiner Interview Summary
Jun 24, 2026
Applicant Interview (Telephonic)
Sep 30, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12766501
BLOOD SEPARATION TUBE COMPRISING CELL ACTIVATION PART
3y 6m to grant Granted Oct 20, 2026
Patent 12758964
PIPETTE TIP WITH TWO POSITIVE ANGLE STEPS
4y 4m to grant Granted Oct 13, 2026
Patent 12752273
SYSTEMS AND METHODS FOR DETERMINING PRESENCE AND/OR CHARACTERISTICS OF TARGET ANALYTES IN A SAMPLE
4y 5m to grant Granted Oct 06, 2026
Patent 12752275
Pressure-Stepped Chemical Reactions and Associated Methods, Systems, Apparatuses, and Articles
4y 3m to grant Granted Oct 06, 2026
Patent 12702982
RACK FOR HOLDING A PLURALITY OF PETRI-DISHES AND TRANSPORT PACKAGING WITH THE RACK
3y 3m to grant Granted Aug 11, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
68%
Grant Probability
99%
With Interview (+52.2%)
3y 6m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 170 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month